Call for Abstract

7th Annual Conference on Stem Cell and Regenerative Medicine, will be organized around the theme “Advanced Approaches In Stem Cell and Regenerative Medicine”

Stem Cell Congress 2016 is comprised of 24 tracks and 57 sessions designed to offer comprehensive sessions that address current issues in Stem Cell Congress 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

An undifferentiated cell of a multicellular creature which is fit for offering ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework, or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes. It is likewise not a flawless arrangement: the new skin has no hair follicles or sweat organs. Research went for enhancing the strategy is continuous.

          The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016

  • Track 1-1Pluripotent stem cells
  • Track 1-2Multipotent stem cells
  • Track 1-3Umbilical cord blood stem cells

Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues . It additionally helps in transplanting immature microorganisms or giving medications that objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation, the recovery of body part is not really another idea.

  • Track 2-1Mesenchymal stem cells therapy
  • Track 2-2Adipose stem cell therapy
  • Track 2-3Stem cell replacement
  • Track 2-4Stem cell clinical management
  • Track 2-5Stem cell therapy for cancer

Somati cell treatment is the organization to people of autologous, allogeneic, or xenogeneic living cells which have been controlled or prepared ex vivo. Assembling of items for substantial cell treatment includes the ex vivo proliferation, development, choice. Substantial cell treatment is seen as a more moderate, more secure methodology since it influences just the focused on cells in the patient, and is not went on to future eras. Substantial quality treatment speaks to standard essential and clinical exploration, in which helpful DNA (either incorporated in the genome or as an outside episome or plasmid) is utilized to treat illness. Most concentrate on extreme hereditary issue, including immunodeficiencies, hemophilia, thalassaemia and cystic fibrosis. Such single quality issue are great possibility for substantial cell treatment.

               With rapid technological advantage in healthcare and its promising results, the use of Stomatic Cell Therapies will increase and the market is expected to have a double digit growth in the forecast period (2015-2025). 

A method of replacing immature blood-forming cells in the bone marrow that have been destroyed by drugs, radiation, or disease. Stem cells are injected into the patient and make healthy blood cells. A stem cell transplant may be autologous (using a patient’s own stem cells that were saved before treatment), allogeneic (using stem cells donated by someone who is not an identical twin), or syngeneic (using stem cells donated by an identical twin).

Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. 


  • Track 4-1Advances in stem cell transplantation
  • Track 4-2Autologous stem cell transplant
  • Track 4-3Cord blood stem cell transplant
  • Track 4-4Embryonic stem cell transplant

Tissue Engineering is the investigation of the development of new connective tissues, or organs, from cells and a collagenous platform to create a completely useful organ for implantation over into the contributor host. Effective improvements in the multidisciplinary field of tissue building have created a novel arrangement of tissue new parts and execution approaches. Investigative advances in biomaterials, foundational microorganisms, development and separation components, and biomimetic situations have made special chances to manufacture tissues in the research facility from blends of designed extracellular networks cells, and organically dynamic particles.

  • Track 5-1Bone regeneration and modern techniques
  • Track 5-2Cartilage regeneration
  • Track 5-3Craniofacial tissue engineering
  • Track 5-4In-situ tissue regeneration
  • Track 5-5Cell-based tissue engineering and cell signalling
  • Track 5-6Morphogenetic proteins
  • Track 5-7Spinal fusion
  • Track 5-8Intervertebral discs repair
  • Track 5-9Nerve tissue engineering

Tissue regenaration therapeutics, making foundational microorganisms for supportive application in regenerative pharmaceutical. Regenerative solution is to offer the body some help with recuperating itself more sufficiently. In regenerative pharmaceutical, cell, tissue and organ substitutes are made to restore normal limit that has been lost.

       There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024. 

  • Track 6-1Stem cells for tissue repair
  • Track 6-2Tissue injury and healing process
  • Track 6-3Cardiac stem cell therapy for regeneration
  • Track 6-4Functional regenerative recovery
An irregular mass of tissue, tumors are a great indication of aggravation, and can be favorable or threatening. Tomour for the most part mirror the sort of tissue they emerge in. Treatment is likewise particular to the area and kind of the tumor. Benevolent tumors can once in a while essentially be overlooked, destructive tumors; choices incorporate chemotherapy, radiation, and surgery. 
Growth cell science, indicative and prognostic malignancy biomarkers 
Tumor undeveloped cells and metastatic development 
Tumor treatment and clinical growth research 
Carcinogenesis and mutagenesis 
Tumorogenesis and tumor development

       The global oncology drugs market is expected to reach at $111.9 billion by 2020.Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.

Gene therapy remains a fairly new and still experimental procedure for the treatment of disease. In addition stem cells are still a relatively new concept and remain a confusing and complicated technology that much of the public struggles to understand. The potential for stem cells to be used in gene therapies is however, a valid one that has important ramifications for treating a range of diseases, many of which currently have no cure.

        The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.

      Stem Cell Biomarker is characterized as a quality or their proteins that are utilized to disengage and recognize immature microorganisms. The other approach to distinguish the undifferentiated organisms is by utilizing utilitarian assays.Molecular biomarkers serve as profitable apparatuses to arrange and segregate embryonic immature microorganisms (ESCs) and to screen their separation state by immunizer based systems. ESCs can offer ascent to any grown-up cell sort and in this way offer colossal potential for regenerative medication and drug revelation. Various biomarkers, for example, certain cell surface antigens, are utilized to dole out pluripotent ESCs

     The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

Biobanks play a crucial role in biomedical research. The wide array of biospecimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism.he process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). 

With a CAGR of 7.9%, overall business segment regard for biorepositories business area is relied upon to be worth US$23.9 billion by 2015. On an overall scale, North America speaks to more than 30% of the business part. While US speaks to the most essential offer of the overall business part regard on a country reason, India and China surpasses the US with respect to advancement rate expected within the near future and leads the world. Bio-coolers show around 7.5% CAGR in the midst of the period 2009-2015, and attest approximately 30% of the business part. Bio-fridges hold second greatest position among the equipment's. Reagents and Consumables address the speediest creating market and guesses US$3.7 billion by 2015. 

      Cell separation is the movement, while a cell changes starting with one cell sort then onto the next. Variety happens various times amid the advancement of a multicellular living being as it changes from a straightforward zygote to a perplexing arrangement of tissues and cell sorts. Separation proceeds in adulthood as grown-up undifferentiated organisms isolate and make completely separated girl cells amid tissue repair and amid typical cell turnover. Some separation happens in light of antigen introduction. Separation drastically changes a phone's size, shape, film potential, metabolic movement, and responsiveness to flags. These progressions are to a great extent because of very controlled changes in quality expression and are the investigation of epigenetics. With a couple of exemptions, cell separation never includes an adjustment in the DNA succession itself. Along these lines, diverse cells can have altogether different physical attributes in spite of having the same genome.

BCC Research projects that the global stem cell market will grow from about $5.6 billionin 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018.
- The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018.
- Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

  • Track 11-1Protection of human stem cells
  • Track 11-2Stem cell and insulin
  • Track 11-3Hematopoietic malignancies
  • Track 11-4Immune cells regulate blood stem cells
  • Track 11-5Cardiac stem cell therapy
  • Track 11-6Prosthodontics and endodontics
  • Track 11-7Tissue engineering in perspective
  • Track 11-8Legislation concerning ATMPs?
  • Track 11-9Mutipotent stem cells

In recent years, the intercrossing of nanotechnology in stem cell biology and biomedicine has led to an emerging new research field, known as stem cell nanotechnology. Stem cell nanotechnology is defined as the application of nanotechnology in stem cells research and development, and it is characterized as highly rapid in development, highly interdisciplinary, and highly controversial.

According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.

'Foundational microorganism Research' is a universal gathering to introduce and talk about ebb and flow points of view in cell and undifferentiated organism research. Immature microorganism Research is the brought together investigation of the properties of cells and living beings and all parts of their communications. Undifferentiated cell Research has the objective to satisfy the overall holes in the change of this art of trust, to serve instantly with answers for all in the need.

  • Track 13-1Stem cell innovations and research In USA
  • Track 13-2Stem cell products and analysis
  • Track 13-3Different cellular classes and scope In UK
  • Track 13-4Clinical trials in USA and Europe
  • Track 13-5Stem cell innovations and research in Germany

Undeveloped cells are removed from the patient's autologous fat. Subsequent to experiencing unique arrangements, they are then utilized for facial restoration wrinkle treatment, body molding furthermore utilized for hair development treatment. The treatment can be consolidated with alternate methodology, for example, facial liposculpture. These apply a capable restoring and regenerative impact on the treated territories. 

With quick mechanical point of interest in human services and its promising results, the utilization of Skin Cell Therapies will increment and the business sector is relied upon to have a twofold digit development in the gauge period (2015-2025).

Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.

  • Genomic analysis and molecular basis of cancer
  • Ubiquitination pathways for cancer therapy
  • Novel therapeutics
  • Translational studies for cancer stem cell-based therapies
  • Epigenetics and cancer stem cells
  • Specific cancer immunotherapy
  • Tissue aging
  • Inflammatory diseases and cancer

        The report predicts the global stem cell therapy market will reach $40 billion in five years by 2020. It also suggests that just the US market will reach $180 billion by 2030.

     Tissue Science and Engineering employs physical, chemical, and biological factors to replace and/or improve biological functions of the cell. The interdisciplinary field of tissue engineering has been one of the most active and quickly expanding disciplines during the past two decades.

       Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Cord blood stem cell is the only type of stem cell that is stored in controlled condition due to its lower volume higher cell count feature. Storage service market is expected grow at 33.4% CAGR from 2013-2020.


     GTR is defined as “procedures that are used to regenerate the lost periodontal structure by using different tissue responses. Many methods are used for tissue regeneration by using different materials like collagen, calcium sulphate, poly tetra flouro ethylene, polyglactin etc.It has become a standard of care in Periodontology and also used in periapical surgery.

     The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate(CAGR) of 22.3%

  • Track 17-1Peridontal therapy/surgery
  • Track 17-2Effects of guided tissue regeneration
  • Track 17-3Advancements in biomedical & tissue engineering techniques
  • Track 17-4Advanced stem cell therapies in tissue engineering
Foundational microorganisms are utilized to recuperate the body , advance recuperation. It has more helpful potential applications. 
It is utilized as a part of Cell Replacement Therapy which is particularly intended to taget the specific organs. 
Improvements of medications that advance cell expansion and separation 
It is likewise used to deliver foundational microorganisms from the patient's skin and blood utilizing Ips innovation 
Change over a particular cell sort to an ancestor cell by transdifferentiation innovation. 
It is likewise utilized as a part of Acquired listening to misfortune, Traumatic cerebrum damage, Cerebral paralysis, Autism, Pediatric stroke .
Regenerative pharmaceuticals have the one of a kind capacity to repair , supplant and recover tissues and organs , influenced because of some harm , infection. These drugs are ability of restoring the usefulness of cells and tissues. These medications have wide appropriateness in treating degenerative scatters including dermatology, cardio vascular, neurodegenerative sicknesses. 
Cell treatment is the quickest developing fragment of regenerative drug. This undeveloped cell treatment is making up the biggest part of this business sector.
  • Track 19-1Delivering on the promise of translational research
  • Track 19-2COGS on market penetration
  • Track 19-3Collaborative capital efficient translation in regenerative medicine
  • Track 19-4Regenerative medicine business model
  • Track 19-5ATMP: European regulatory framework
  • Track 19-6Ethics and applications of regenerative medicine
  • Track 19-7Trends in biobanking and preanalytics
  • Track 19-8Clinical trials and regenerative medicine

    Computational Biology, sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

A biomaterial is any matter, surface, or construct that interacts with living systems. As a science, biomaterials is about fifty years old. The study of biomaterials is calledbiomaterials science or biomaterials engineering. It has experienced steady and strong growth over its history, with many companies investing large amounts of money into the development of new products.

The report studies the global biomaterials market for the forecast period of 2015 to 2020. This market is expected to reach USD 130.57 Billion by 2020 from USD 62.06 Billion in 2015, at a CAGR of 16%.

Stem cell research offers incredible guarantee for comprehension fundamental systems of human improvement and separation, and additionally the expectation for new medications for maladies, for example, diabetes, spinal string damage, Parkinson's ailment, and myocardial localized necrosis. Be that as it may, human undifferentiated organism (hSC) explore likewise raises sharp moral and political debates. The induction of pluripotent undifferentiated organism lines from oocytes and fetuses is laden with question about the onset of human personhood. The reinventing of substantial cells to deliver affected pluripotent undifferentiated organisms maintains a strategic distance from the moral issues particular to embryonic foundational microorganism research. In any hSC research, in any case, troublesome situations emerge with respect to delicate downstream research, agree to give materials for hSC research, early clinical trials of hSC treatments, and oversight of hSC examination. These moral and approach issues should be examined alongside exploratory difficulties to guarantee that undifferentiated cell examination is done in a morally fitting way. This article gives a basic investigation of these issues and how they are tended to in current arrangements.

Trends and  Perspectives on the Evolving International Landscape presents a comprehensive analysis of the growth and development of the stem cell field, with particular focus on embryonic stem (ES) cell and induced pluripotent stem (iPS) cell research outputs.

       MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

  • Track 23-1Trends in the Stem cell& Regenerative Medicine Industry
  • Track 23-2Stem cell& Regenerative Medicine in drug development

Work on regenerative medicine is not only happening in academic laboratories, novel cell-based therapies are also being developed by commercial companies in Europe and across the world